CRISPR/Cas therapeutic strategies for autosomal dominant disorders is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R24EY027285-01A1
Translational Gene Therapy for CNGB1 Retinitis Pigmentosa
National Institutes of Health
Grant: 5R01EY024698-10
Gene Editing and Silencing in Phototransduction
National Institutes of Health
Grant: 5R24EY028758-05
Therapeutic gene editing and multimodal imaging in juvenile macular degeneration
National Institutes of Health
Grant: 1U54OD020351-01
Project 1 - Epilepsy Project
National Institutes of Health
Grant: 2R01EY009076-21
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITY
National Institutes of Health
Grant: 5R01EY026682-04
Mechanistic Studies on Regenerative Medicine Approaches to Childhood Blindness
National Institutes of Health
Grant: 5R21AG050437-02
Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells
National Institutes of Health
Grant: 5U01EY030580-02
Precision genome surgery in autologous stem cell transplant
National Institutes of Health
Grant: 2R01EY018213-06A1
Defining Barriers to Gene Therapy
National Institutes of Health
Grant: 3P30CA013696-21S1
CANCER CENTER CORE SUPPORT GRANT
National Institutes of Health
Grant: 2P30EY019007-06A1
Core Facilities for Vision Research
Fields of Study
Keywords
Sustainable Development Goals